{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:59:21Z","timestamp":1779361161358,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11011-018-0325-0","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T20:27:29Z","timestamp":1538771249000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association between clusterin concentration and dementia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Caiping","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunkui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","volume":"33","author":"P Bertrand","year":"1995","unstructured":"Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res 33:174\u2013178","journal-title":"Brain Res Mol Brain Res"},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-015-0024-9","volume":"10","author":"K Bettens","year":"2015","unstructured":"Bettens K, Vermeulen S, Van Cauwenberghe C, Heeman B, Asselbergh B, Robberecht C, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K (2015) Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations. Mol Neurodegener 10:30","journal-title":"Mol Neurodegener"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fnagi.2016.00179","volume":"8","author":"R Cai","year":"2016","unstructured":"Cai R, Han J, Sun J, Huang R, Tian S, Shen Y, Dong X, Xia W, Wang S (2016) Plasma Clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front Aging Neurosci 8:179","journal-title":"Front Aging Neurosci"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-7-41","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Wang M, Turko IV (2012) Mass spectrometry quantification of clusterin in the human brain. Mol Neurodegener 7:41","journal-title":"Mol Neurodegener"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41:193\u2013202","journal-title":"Neuron"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"208.e1","DOI":"10.1016\/j.neurobiolaging.2015.09.009","volume":"37","author":"Y Deming","year":"2016","unstructured":"Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C (2016) A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiol Aging 37:208.e1\u2013208.e9","journal-title":"Neurobiol Aging"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2013.4560","volume":"71","author":"RS Desikan","year":"2014","unstructured":"Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM (2014) The role of clusterin in amyloid-beta-associated neurodegeneration. JAMA NEUROL 71:180\u2013187","journal-title":"JAMA NEUROL"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3892\/etm.2016.3734","volume":"12","author":"W Du","year":"2016","unstructured":"Du W, Tan J, Xu W, Chen J, Wang L (2016) Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: a review and meta-analysis of case-control studies. EXP THER MED 12:2915\u20132927","journal-title":"EXP THER MED"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clinbiochem.2015.10.014","volume":"49","author":"L Dukic","year":"2016","unstructured":"Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, Diamandis EP (2016) The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clin Biochem 49:213\u2013218","journal-title":"Clin Biochem"},{"key":"325_CR10","first-page":"1846","volume":"33","author":"R Ferrari","year":"2012","unstructured":"Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P (2012) Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiol Aging 33:1846\u20131847","journal-title":"Neurobiol Aging"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3940(95)11565-7","volume":"191","author":"A Golabek","year":"1995","unstructured":"Golabek A, Marques MA, Lalowski M, Wisniewski T (1995) Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett 191:79\u201382","journal-title":"Neurosci Lett"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","volume":"29","author":"EM Golebiewska","year":"2015","unstructured":"Golebiewska EM, Poole AW (2015) Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29:153\u2013162","journal-title":"Blood Rev"},{"key":"325_CR13","first-page":"18","volume":"3","author":"VB Gupta","year":"2016","unstructured":"Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN (2016) Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian imaging. Biomarkers and Lifestyle Study of Aging Alzheimers Dement (Amst) 3:18\u201326","journal-title":"Biomarkers and Lifestyle Study of Aging Alzheimers Dement (Amst)"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","volume":"54","author":"S Hakobyan","year":"2016","unstructured":"Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, Liu B, Harris CL, Lovestone S, Morgan BP (2016) Complement biomarkers as predictors of disease progression in Alzheimer's disease. J Alzheimers Dis 54:707\u2013716","journal-title":"J Alzheimers Dis"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1046\/j.1471-4159.1996.66062429.x","volume":"66","author":"SD Harr","year":"1996","unstructured":"Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ (1996) Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66:2429\u20132435","journal-title":"J Neurochem"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2013.09.040","volume":"35","author":"TM Hughes","year":"2014","unstructured":"Hughes TM, Lopez OL, Evans RW, Kamboh MI, Williamson JD, Klunk WE, Mathis CA, Price JC, Cohen AD, Snitz BE, Dekosky ST, Kuller LH (2014) Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging 35:802\u2013807","journal-title":"Neurobiol Aging"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1021\/pr101221h","volume":"10","author":"L Ijsselstijn","year":"2011","unstructured":"Ijsselstijn L, Dekker LJM, Koudstaal PJ, Hofman A, Sillevis Smitt PAE, Breteler MMB, Luider TM (2011) Serum clusterin levels are not increased in presymptomatic Alzheimers disease. J Proteome Res 10:2006\u20132010","journal-title":"J Proteome Res"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0004563213503456","volume":"51","author":"W Jongbloed","year":"2014","unstructured":"Jongbloed W, Herrebout MA, Blankenstein MA, Veerhuis R (2014) Quantification of clusterin in paired cerebrospinal fluid and plasma samples. Ann Clin Biochem 51:557\u2013567","journal-title":"Ann Clin Biochem"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3233\/JAD-150036","volume":"46","author":"W Jongbloed","year":"2015","unstructured":"Jongbloed W, van Dijk KD, Mulder SD, van de Berg WD, Blankenstein MA, van der Flier W, Veerhuis R (2015) Clusterin levels in plasma predict cognitive decline and progression to Alzheimer's disease. J Alzheimers Dis 46:1103\u20131110","journal-title":"J Alzheimers Dis"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5115\/acb.2011.44.3.169","volume":"44","author":"N Kim","year":"2011","unstructured":"Kim N, Choi WS (2011) Proapoptotic role of nuclear clusterin in brain. Anatomy & Cell Biology 44:169\u2013175","journal-title":"Anatomy & Cell Biology"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcp.22836","volume":"227","author":"N Kim","year":"2012","unstructured":"Kim N, Yoo JC, Han JY, Hwang EM, Kim YS, Jeong EY, Sun CH, Yi GS, Roh GS, Kim HJ (2012) Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain. J Cell Physiol 227:1157\u20131167","journal-title":"J Cell Physiol"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/exnr.1998.6892","volume":"154","author":"AM Lidstrom","year":"1998","unstructured":"Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K (1998) Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 154:511\u2013521","journal-title":"Exp Neurol"},{"key":"325_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JAD-2001-3501","volume":"3","author":"AM Lidstrom","year":"2001","unstructured":"Lidstrom AM, Hesse C, Rosengren L, Fredman P, Davidsson P, Blennow K (2001) Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke. J Alzheimers Dis 3:435\u2013442","journal-title":"J Alzheimers Dis"},{"key":"325_CR24","first-page":"332r","volume":"8","author":"CC Liu","year":"2016","unstructured":"Liu CC, Zhao N, Yamaguchi Y, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G (2016) Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer's disease. Sci Transl Med 8:332r\u2013344r","journal-title":"Sci Transl Med"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.neurobiolaging.2013.08.015","volume":"35","author":"SJ Lu","year":"2014","unstructured":"Lu SJ, Li HL, Sun YM, Liu ZJ, Yang P, Wu ZY (2014) Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease. Neurobiol Aging 35:2656\u20132659","journal-title":"Neurobiol Aging"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1172\/JCI26885","volume":"115","author":"IC Macaulay","year":"2005","unstructured":"Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA (2005) Platelet genomics and proteomics in human health and disease. J Clin Invest 115:3370\u20133377","journal-title":"J Clin Invest"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"15546","DOI":"10.1038\/srep15546","volume":"5","author":"Y Meng","year":"2015","unstructured":"Meng Y, Li H, Hua R, Wang H, Lu J, Yu X, Zhang C (2015) A correlativity study of plasma APL1beta28 and clusterin levels with MMSE\/MoCA\/CASI in aMCI patients. Sci Rep 5:15546","journal-title":"Sci Rep"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ageing\/afr171","volume":"41","author":"EB Mukaetova-Ladinska","year":"2012","unstructured":"Mukaetova-Ladinska EB, Abdel-All Z, Dodds S, Andrade J, Alves Da Silva J, Kalaria RN, O'Brien JT (2012) Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study. Age Ageing 41:408\u2013412","journal-title":"Age Ageing"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/gps.4145","volume":"30","author":"EB Mukaetova-Ladinska","year":"2015","unstructured":"Mukaetova-Ladinska EB, Abdel-All Z, Andrade J, Alves DSJ, O'Brien JT, Kalaria RN (2015) Plasma and platelet clusterin ratio is altered in Alzheimer's disease patients with distinct neuropsychiatric symptoms: findings from a pilot study. Int J Geriatr Psychiatry 30:368\u2013375","journal-title":"Int J Geriatr Psychiatry"},{"key":"325_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/15672050113106660162","volume":"10","author":"GM Mullan","year":"2013","unstructured":"Mullan GM, McEneny J, Fuchs M, McMaster C, Todd S, McGuinness B, Henry M, Passmore AP, Young IS, Johnston JA (2013) Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease. Curr Alzheimer Res 10:973\u2013978","journal-title":"Curr Alzheimer Res"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","volume":"48","author":"AM Nilselid","year":"2006","unstructured":"Nilselid AM, Davidsson P, Nagga K, Andreasen N, Fredman P, Blennow K (2006) Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int 48:718\u2013728","journal-title":"Neurochem Int"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","volume":"61","author":"T Nuutinen","year":"2009","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61:89\u2013104","journal-title":"Brain Res Rev"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0b013e31827f0889","volume":"80","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN (2013) Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 80:359\u2013365","journal-title":"Neurology"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63\u201375","journal-title":"Alzheimers Dement"},{"key":"325_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","volume":"118","author":"M Puchades","year":"2003","unstructured":"Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 118:140\u2013146","journal-title":"Brain Res Mol Brain Res"},{"key":"325_CR36","first-page":"53","volume":"5","author":"JL Richens","year":"2014","unstructured":"Richens JL, Vere KA, Light RA, Soria D, Garibaldi J, Smith AD, Warden D, Wilcock G, Bajaj N, Morgan K, O'Shea P (2014) Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. International Journal of Molecular Epidemiology and Genetics 5:53\u201370","journal-title":"International Journal of Molecular Epidemiology and Genetics"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbrc.2007.02.148","volume":"356","author":"V Savkovic","year":"2007","unstructured":"Savkovic V, Gantzer H, Reiser U, Selig L, Gaiser S, Sack U, Kloppel G, Mossner J, Keim V, Horn F, Bodeker H (2007) Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties. Biochem Biophys Res Commun 356:431\u2013437","journal-title":"Biochem Biophys Res Commun"},{"key":"325_CR38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EM Schrijvers","year":"2011","unstructured":"Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA 305:1322\u20131326","journal-title":"JAMA"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-2011-110251","volume":"25","author":"B Schurmann","year":"2011","unstructured":"Schurmann B, Wiese B, Bickel H, Weyerer S, Riedel-Heller SG, Pentzek M, Bachmann C, Williams J, van den Bussche H, Maier W, Jessen F (2011) Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. J Alzheimers Dis 25:421\u2013424","journal-title":"J Alzheimers Dis"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neulet.2015.02.040","volume":"591","author":"P Shuai","year":"2015","unstructured":"Shuai P, Liu Y, Lu W, Liu Q, Li T, Gong B (2015) Genetic associations of CLU rs9331888 polymorphism with Alzheimer's disease: a meta-analysis. Neurosci Lett 591:160\u2013165","journal-title":"Neurosci Lett"},{"key":"325_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050237","volume":"7","author":"E Silajdzic","year":"2012","unstructured":"Silajdzic E, Minthon L, Bjorkqvist M, Hansson O (2012) No diagnostic value of plasma clusterin in Alzheimer's disease. PLoS One 7:e50237","journal-title":"PLoS One"},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2015.81","volume":"11","author":"A Solomon","year":"2015","unstructured":"Solomon A, Soininen H (2015) Dementia: risk prediction models in dementia prevention. NAT REV NEUROL 11:375\u2013377","journal-title":"NAT REV NEUROL"},{"key":"325_CR43","doi-asserted-by":"crossref","unstructured":"Song F, Poljak A, Crawford J, Kochan NA, Wen W, Cameron B, Lux O, Brodaty H, Mather K, Smythe GA, Sachdev PS (2012). Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals PLOS ONE 7","DOI":"10.1371\/journal.pone.0034078"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"26027","DOI":"10.1038\/srep26027","volume":"6","author":"L Tan","year":"2016","unstructured":"Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT (2016) Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Sci Rep 6:26027","journal-title":"Sci Rep"},{"key":"325_CR45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Guntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67:739\u2013748","journal-title":"Arch Gen Psychiatry"},{"key":"325_CR46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","volume":"59","author":"M Thambisetty","year":"2012","unstructured":"Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, Guntert A, Kraut M, Ferrucci L, Davatzikos C, Lovestone S, Resnick SM (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. NeuroImage 59:212\u2013217","journal-title":"NeuroImage"},{"key":"325_CR47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000351207","volume":"59","author":"IP Trougakos","year":"2013","unstructured":"Trougakos IP (2013) The molecular chaperone apolipoprotein J\/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review. Gerontology 59:514\u2013523","journal-title":"Gerontology"},{"key":"325_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12:357\u2013367","journal-title":"Lancet Neurol"},{"key":"325_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166369","volume":"11","author":"VY Vishnu","year":"2016","unstructured":"Vishnu VY, Modi M, Sharma S, Mohanty M, Goyal MK, Lal V, Khandelwal N, Mittal BR, Prabhakar S (2016) Role of plasma Clusterin in Alzheimer's disease-a pilot study in a tertiary Hospital in Northern India. PLoS One 11:e166369","journal-title":"PLoS One"},{"key":"325_CR50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.dadm.2016.06.005","volume":"3","author":"G Weinstein","year":"2016","unstructured":"Weinstein G, Beiser AS, Preis SR, Courchesne P, Chouraki V, Levy D, Seshadri S (2016) Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke. Alzheimers Dement (Amst) 3:103\u2013109","journal-title":"Alzheimers Dement (Amst)"},{"key":"325_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-2011-111844","volume":"29","author":"YY Xing","year":"2012","unstructured":"Xing YY, Yu JT, Cui WZ, Zhong XL, Wu ZC, Zhang Q, Tan L (2012) Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. J Alzheimers Dis 29:515\u2013519","journal-title":"J Alzheimers Dis"},{"key":"325_CR52","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21:2312\u20132322","journal-title":"FASEB J"},{"key":"325_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"J Yu","year":"2012","unstructured":"Yu J, Tan L (2012) The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol Neurobiol 45:314\u2013326","journal-title":"Mol Neurobiol"},{"key":"325_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00702-014-1260-9","volume":"122","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhang D, Jiang Y, Wu L, Shang H, Liu J, Feng R, Liao M, Zhang L, Liu Y, Liu G, Li K (2015) CLU rs2279590 polymorphism contributes to Alzheimer's disease susceptibility in Caucasian and Asian populations. J Neural Transm (Vienna) 122:433\u2013439","journal-title":"J Neural Transm (Vienna)"},{"key":"325_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103187","volume":"9","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger JJ, Zerbinatti C (2014) Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer's disease. PLoS One 9:e103187","journal-title":"PLoS One"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0325-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T04:18:37Z","timestamp":1605154717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0325-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0325-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"31 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}